Trial Profile
A Phase I/II, Open Label, Controlled Study to Evaluate the Safety and Efficacy of AppliGel-G [Gentamicin Sulfate Topical Gel] for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers in Patients With Type 1 and Type 2 Diabetes
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 18 May 2015
Price :
$35
*
At a glance
- Drugs Gentamicin (Primary) ; Ciprofloxacin; Doxycycline
- Indications Bacterial skin diseases; Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Royer Biomedical
- 13 May 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record
- 12 Feb 2014 New trial record